Cellular and Molecular Life Sciences CMLS

, Volume 61, Issue 23, pp 2954–2964 | Cite as

Oncogenic protein tyrosine kinases

Dysfunction of the RET receptor in human cancer
  • M. Santoro
  • F. Carlomagno
  • R. M. Melillo
  • A. Fusco
Multi-author Review

Abstract.

RET is the receptor for glial-derived neurotrophic factor growth factors. It is a paradigm of a single gene that causes different types of human cancer when targeted by different genetic alterations. Like other receptor tyrosine kinases, once activated, RET recruits a variety of signaling molecules that mediate biological responses. Here we review data on the signaling pathways that lead to RET-mediated cell transformation and recent evidence that manipulation of RET holds promise for thyroid cancer treatment.

Key words.

Thyroid tyrosine kinase inhibitors RET MEN2 papillary thyroid carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel 2004

Authors and Affiliations

  • M. Santoro
    • 1
  • F. Carlomagno
    • 1
  • R. M. Melillo
    • 1
  • A. Fusco
    • 1
  1. 1.Dipartimento di Biologia e Patologia Cellulare e MolecolareUniversity ‘Federico II’NaplesItaly

Personalised recommendations